Monitor the August 6 appeal submission and subsequent Nasdaq panel hearing timeline. The company may need to pursue another reverse stock split or capital raise to regain bid price compliance, but the prior split within one year limits options. If delisted, expect significant downside and reduced trading volume.
Price Chart
Executive Summary
bioAffinity Technologies received a Nasdaq staff determination that its common stock bid price closed below $1.00 for 30 consecutive business days, violating the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Because the company effected a 1-for-30 reverse stock split within the prior year (September 19, 2025), it is not eligible for the standard 180-day compliance period. The company plans to appeal on August 6, 2026, which will temporarily stay delisting pending a panel decision, but there is no assurance of regaining compliance.
Key Facts
- Nasdaq staff determination received July 30, 2026 for bid price below $1.00 for 30 consecutive business days (June 16–July 29, 2026)
- Company ineligible for 180-day compliance period due to 1-for-30 reverse stock split on September 19, 2025 (within prior year)
- Appeal to be submitted by August 6, 2026; hearing will stay delisting pending panel decision
- No assurance that the panel will grant an extension or that the company will regain compliance
Financial Impact
Delisting risk is material for a $5M market cap company; loss of Nasdaq listing would severely reduce liquidity and institutional ownership, likely forcing trading to OTC markets
Risk Factors
- Nasdaq panel may deny extension, leading to delisting and OTC trading
- Company may be unable to regain bid price compliance within any granted extension period
- Loss of Nasdaq listing could trigger debt covenants, accelerate liabilities, or reduce access to capital
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-035672 |
| Document: 0001493152-26-035672-index-headers.html | 0001493152-26-035672 |
| Document: 0001493152-26-035672-index.html | 0001493152-26-035672 |
| Document: 0001493152-26-035672.txt | 0001493152-26-035672 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | DEF 14A | $2.81 | awaiting T+1 | — | $2.93 (+4.27%) |
Oct 15, 2026 12d ago | 8-K | $3.96 $3.73 | ▼ −5.81% | ▼ −4.70% | $2.93 (−26.01%) |
Oct 13, 2026 14d ago | 8-K | $3.63 $3.56 | ▼ −1.79% | ▼ −0.71% | $2.93 (−19.17%) |
Oct 9, 2026 17d ago | 8-K | $3.90 $3.63 | ▲ +7.05% | ▲ +7.04% | $2.93 (+24.87%) |
Oct 9, 2026 17d ago | 424B5 | $4.73 $3.90 | ▲ +17.46% | ▲ +17.40% | $2.93 (+37.99%) |
Oct 9, 2026 17d ago | 424B5 | $4.73 $3.90 | ▼ −17.46% | ▼ −17.40% | $2.93 (−37.99%) |
Oct 8, 2026 19d ago | 8-K | $5.64 $4.73 | ▼ −16.22% | ▼ −16.82% | $2.93 (−48.05%) |
Oct 6, 2026 21d ago | 8-K | $6.06 $6.16 | ▲ +1.65% | ▲ +1.89% | $2.93 (−51.65%) |
Sep 30, 2026 27d ago | 8-K | $6.56 $6.15 | ▼ −6.33% | ▼ −6.50% | $2.93 (−55.34%) |
Sep 22, 2026 5w ago | 8-K | $8.56 $7.94 | ▼ −7.19% | ▼ −6.47% | $2.93 (−65.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers